Myasthenia Gravis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Clinical Trials
• Forums

Safety and Efficacy of ALXN1720 in Adults With Generalized Myasthenia Gravis
Condition:   Generalized Myasthenia Gravis Interventions:   Combination Product: ALXN1720;   Combination Product: Placebo Sponsor:   Alexion Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 27, 2022 Category: Research Source Type: clinical trials

An Open-label Study to Evaluate the Safety, Tolerability, and Efficacy of Subcutaneous Zilucoplan in Participants With Generalized Myasthenia Gravis Who Were Previously Receiving Intravenous Complement Component 5 Inhibitors
Condition:   Generalized Myasthenia Gravis Intervention:   Drug: zilucoplan (RA101495) Sponsor:   UCB Biopharma SRL Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 25, 2022 Category: Research Source Type: clinical trials